Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Role of myeloperoxidase as predictor of systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
Samimi-Fard S, Dominguez-Rodriguez A, Abreu-Gonzalez P, Enjuanes-Grau C, Blanco-Palacios G, Hernandez-Baldomero IF, Bosa-Ojeda F, Marrero-Rodríguez F. Samimi-Fard S, et al. Among authors: hernandez baldomero if. Am J Cardiol. 2009 Sep 1;104(5):634-7. doi: 10.1016/j.amjcard.2009.04.049. Epub 2009 Jun 24. Am J Cardiol. 2009. PMID: 19699336
Change in growth differentiation factor 15, but not C-reactive protein, independently predicts major cardiac events in patients with non-ST elevation acute coronary syndrome.
Dominguez-Rodriguez A, Abreu-Gonzalez P, Hernandez-Baldomero IF, Avanzas P, Bosa-Ojeda F. Dominguez-Rodriguez A, et al. Among authors: hernandez baldomero if. Mediators Inflamm. 2014;2014:929536. doi: 10.1155/2014/929536. Epub 2014 Apr 15. Mediators Inflamm. 2014. PMID: 24839357 Free PMC article.
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT).
Rossello X, Raposeiras-Roubin S, Latini R, Dominguez-Rodriguez A, Barrabés JA, Sánchez PL, Anguita M, Fernández-Vázquez F, Pascual-Figal D, De la Torre Hernandez JM, Ferraro S, Vetrano A, Pérez-Rivera JA, Prada-Delgado O, Escalera N, Staszewsky L, Pizarro G, Agüero J, Pocock S, Ottani F, Fuster V, Ibáñez B; REBOOT-CNIC investigators. Rossello X, et al. Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):291-301. doi: 10.1093/ehjcvp/pvab060. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 34351426 Clinical Trial.
Characterization of hereditary transthyretin cardiac amyloidosis in Spain.
Álvarez Rubio J, Manovel Sánchez AJ, González-Costello J, García-Pavía P, Limeres Freire J, García-Pinilla JM, Zorio Grima E, García-Álvarez A, Valverde Gómez M, Espinosa Castro MÁ, Barge-Caballero G, Gimeno Blanes JR, Bosch Rovira MT, Rincón Díaz LM, Aibar Arregui MÁ, Gallego-Delgado M, Jiménez-Jáimez J, Martínez Moreno M, Basurte M, Arana Achaga X, Hernández Baldomero IF, Ripoll-Vera T; AC-TTRv-Spain Investigator Group. Álvarez Rubio J, et al. Among authors: hernandez baldomero if. Rev Esp Cardiol (Engl Ed). 2022 Jun;75(6):488-495. doi: 10.1016/j.rec.2021.07.020. Epub 2021 Oct 26. Rev Esp Cardiol (Engl Ed). 2022. PMID: 34711514 English, Spanish.